Materias dentro de su búsqueda.
Mostrando 1,181 - 1,200 Resultados de 5,148 Para Buscar '"Ph. D."', tiempo de consulta: 1.52s Limitar resultados
  1. 1181
    “…Kimbrough, PhD, AbbVie: Grant/Research Support|Basilea: Grant/Research Support|Pfizer: Grant/Research Support|Shionogi: Grant/Research Support Valerie Kantro, BA, AbbVie: Grant/Research Support|Pfizer: Grant/Research Support|Shionogi: Grant/Research Support Dee Shortridge, PhD, Melinta: Grant/Research Support|Shionogi: Grant/Research Support Helio S. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2172. Activity of Cefiderocol and Comparator Agents Against Molecularly Characterized Multidrug-resistant Enterobacterales Clinical Isolates from United States Hospitals (2020–2022)
  2. 1182
    “…Patel, MD MPH, Gilead: Advisor/Consultant|Gilead: Grant/Research Support|Roche: Advisor/Consultant|ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support Zandraetta Tims-Cook, MD, ViiV Healthcare: Speaker Nanlesta Pilgrim, PhD, ViiV Healthcare: Employment|ViiV Healthcare: Stocks/Bonds Amber Haley, PhD, ViiV Healthcare: Former Employment Kenneth Sutton, MA, ViiV Healthcare: Employment|ViiV Healthcare: Stocks/Bonds Alison Gaudion, PhD, ViiV Healthcare: Employment|ViiV Healthcare: Stocks/Bonds Deanna Merrill, PharmD, MBA, AAHIVP, ViiV Healthcare: Employment|ViiV Healthcare: Stocks/Bonds Rimgaile Urbaityte, MSc, GSK: Employment|GSK: Stocks/Bonds Bo Li, PhD, GSK: Employment|GSK: Stocks/Bonds David Andrae, PhD, Evidera: Employment Abigail Herbst, MPH, Evidera: Empoyment|ViiV Healthcare: Grant/Research Support Harmony Garges, MD, GSK: Stocks/Bonds|Medexus Pharmacy: Board Member|ViiV Healthcare: Empoyment Maggie Czarnogorski, MD MPH, ViiV Healthcare: Employment|ViiV Healthcare: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1547. Integrating Long-acting Injectable Cabotegravir for PrEP into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex with Men: Results from the PILLAR & EBONI Studies
  3. 1183
    “…DISCLOSURES: Boudewijn L. DeJonge, PhD, Shionogi Inc.: Employee Sean T. Nguyen, PharmD, Shionogi: Employee|Shionogi, Inc: Employee Jason J. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2762. Activity of Cefiderocol and Comparator Agents Against Difficult to Treat Resistance (DTR) Gram-negative Isolates, Collected During 2020-2022 as Part of SENTRY Antimicrobial Surveillance Program
  4. 1184
    “…Kelly, PhD, Pfizer: Employee|Pfizer: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2627. Natural History of RSV Infection in Outpatient Episodes Among Children in the United States using Two EHR Data Sources by COVID-19 Era
  5. 1185
    “…DISCLOSURES: Arolyn Conwill, PhD, Day Zero Diagnostics: salary|Day Zero Diagnostics: Ownership Interest Mohamad Sater, PhD, Day Zero Diagnostics: Employee|Day Zero Diagnostics: Stocks/Bonds Nicholas Worley, PhD, Day Zero Diagnostics: Salary|Day Zero Diagnostics: Ownership Interest Jason Wittenbach, PhD, Day Zero Diagnostics: Salary|Day Zero Diagnostics: Ownership Interest Miriam H. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    966. Large-Scale Evaluation of AST Prediction using Resistance Marker Presence/Absence vs. Machine Learning on WGS Data
  6. 1186
    “…FUNDING: GlaxoSmithKline Biologicals SA ACKNOWLEDGMENT: N Bulik/Q Deraedt (Modis c/o GSK) provided writing/editorial support DISCLOSURES: Tino Schwarz, PhD, GSK group of companies (Scientific Research Study Investigator, Speaker’s Bureau) Christine Grigat, MD, GSK group of companies (Scientific Research Study Investigator) Dan Apter, MD, PhD, GSK group of companies (Research Grant or Support) Peter Csonka, MD, PhD, GSK group of companies (Scientific Research Study Investigator) Thi Lien-Anh Nguyen, PhD, GSK group of companies (Employee, Shareholder) Feng F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1239. Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated
  7. 1187
    “…Puckett, BA, COVIA Health Solutions (Employee) Engels N. Obi, PhD, Merck & Co. (Employee, Shareholder) Sachin Kamal-Bahl, PhD, AbbVie (Consultant)Arena Pharmaceuticals, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    15. Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficiaries in the U.S
  8. 1188
    “…Tarbell, PhD, Adagio Therapeutics, Inc. (Independent Contractor) Kristin Narayan, PhD, Adagio Therapeutics, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1089. Use of a Whole-Body Quantitative System Pharmacology Physiologically-Based Pharmacokinetic (QSP/PBPK) Model to Support Dose Selection of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Prevention of Coronavirus Disease (COVID-19)
  9. 1189
    “….: Stocks/Bonds Joanne Tomassini, Ph.D., Moderna, Inc.: Advisor/Consultant Xing Chen, Sc.D., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Ying Chang, M.S., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Andrea Sutherland, M.D., MPH, Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds David Montefiori, Ph.D., Moderna, Inc.: Grant/Research Support Bethany Girard, Ph.D., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Darin Edwards, Ph.D., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Jing Feng, M.S., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Honghong Zhou, Ph.D., Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Lindsey R. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB750. Safety and Immunogenicity of a Bivalent Omicron-Containing Booster Vaccine against COVID-19
  10. 1190
    por Rosser, Harry Edwin, 1916-
    Publicado 1971
    Tesis Libro
    Beyond revolution: the social concern of Moisés Sáenz, Mexican educator (1888-1941) /
  11. 1191
    “…DISCLOSURES: Christine Wiggins, B.S., Takeda Pharmaceutical Company: Stocks/Bonds Elizabeth Deriso, PhD, Takeda: Employee Klemen Strle, PhD, Takeda: I am an employee of Takeda. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    255. Borrelia-specific antibody profiling in joint fluid distinguishes antibiotic-refractory Lyme arthritis from antibiotic-responsive arthritis
  12. 1192
    “…Nolte, PhD, Karius: Stocks/Bonds Timothy A. Blauwkamp, PhD, Karius: Board Member|Karius: Ownership Interest Sivan Bercovici, PhD, Karius: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    873. Detection of Monkeypox Virus Using Microbial Cell-free DNA: Demonstrating the Potential of Agnostic Sequencing for Real Time Identification of an Emerging Pathogen
  13. 1193
    “…DISCLOSURES: Stephen M. Kissler, PhD, ModernaTx: Advisor/Consultant Keya Joshi, PhD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Nicolas Van de Velde, PhD, Moderna, Inc.: Salary|Moderna, Inc.: Stocks/Bonds Nevena Vicic, MSc, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Yoonyoung Park, ScD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Deborah Rudin, MD, Moderna, Inc.: Employee|Moderna, Inc.: Stocks/Bonds Parinaz Ghaswalla, PhD, Moderna, Inc: Employee|Moderna, Inc: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1635. Assessing the Potential Reduction in Morbidity and Mortality Attainable by Delayed Influenza Vaccine Strain Selection
  14. 1194
    “…DISCLOSURES: S J Ryan Arends, PhD, Cipla: Grant/Research Support|GSK: Grant/Research Support Renuka Kapoor, PhD, GSK: Grant/Research Support Didem Torumkuney, PhD, GSK: Grant/Research Support Nicole E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2159. Analysis of Resistance to Oral Standard-of-Care Antibiotics for Urinary Tract Infections Caused By Escherichia coli and Staphylococcus saprophyticus Collected in the United States in 2022
  15. 1195
    “…DISCLOSURES: Maria Sundaram, PhD, MSPH, GlaxoSmithKline: Grant/Research Support Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support Gabriele Neumann, Ph.D., FluGen: US-20110150925-A1, US-20100021499-A1, US 8,163,523 B2|FluGen: Ownership Interest|FluGen: Stocks/Bonds Edward Belongia, MD, Seqirus: Grant/Research Support Huong McLean, PhD, MPH, Seqirus: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    446. Post-Acute Sequelae of COVID-19 in a Rural Wisconsin Community Prospective Cohort
  16. 1196
    “…DISCLOSURES: Emmanuel Roilides, MD, PhD, Gilead: Advisor/Consultant|GSK: Grant/Research Support|MSD: Advisor/Consultant|MSD: Grant/Research Support|Mundipharma: Advisor/Consultant|Pfizer: Grant/Research Support|Scynexis: Grant/Research Support Richard England, MD, PhD, Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds Margaret Tawadrous, MD, MS, Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds Jean Yan, M.S., Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds Elena Soto, PhD, Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds Gregory Stone, PhD, Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds Shweta Kamat, MD, Pfizer: Employee of Pfizer|Pfizer: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    2890. Pharmacokinetics, Safety, and Efficacy of Ceftazidime-Avibactam in Neonates and Young Infants with Bacterial Infections: Results from a Phase 2a, 2-part, Open-label, Non-randomized, Multicenter Trial
  17. 1197
    “…DISCLOSURES: Frederick Angulo, DVM PhD, Pfizer Vaccines: Employee|Pfizer Vaccines: Stocks/Bonds Pingping Zhang, MS, Pfizer Vaccines: Stocks/Bonds Dagmar Krivohlavkova, M.D., Pfizer Vaccine: Employee|Pfizer Vaccine: Stocks/Bonds Lisa Harper, M.S., Pfizer Vaccines: Stocks/Bonds Juanita Edwards, B.S., Pfizer Vaccines: Stocks/Bonds Cody Bender, M.S., Pfizer Vaccines: Stocks/Bonds Andreas Pilz, PhD, Pfizer Vaccines: Stocks/Bonds Wilhelm Erber, PhD, Pfizer Vaccines: Stocks/Bonds Harish Madhava, M.D., Pfizer Vaccines: Stocks/Bonds Jennifer Moïsi, PhD, Pfizer Vaccines: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1757. Effectiveness of vaccination against tick-borne encephalitis in the Czech Republic, 2018-2022
  18. 1198
    “…Mould-Quevedo, PhD, CSL Seqirus Inc.: Employee|CSL Seqirus Inc.: Employee|CSL Seqirus Inc.: Stocks/Bonds|CSL Seqirus Inc.: Stocks/Bonds…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1166. The Cost-Effectiveness Evidence of Enhanced Influenza Vaccines in Adults ≥65 Years of Age: A Literature Review and Decision-Making Implications
  19. 1199
    “…|Pfizer: Stocks/Bonds Adriano Arguedas, Medical director, Pfizer: Emplyee|Pfizer: Stocks/Bonds Alejandro D. Cane, MD, PhD, Pfizer: Stocks/Bonds Maria J Tort, PhD, Pfizer Inc: Stocks/Bonds Anna Pierce, BBA, Pfizer, Inc.: Grant/Research Support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States
  20. 1200
    “…[Image: see text] DISCLOSURES: Joan Mannick, MD, resTORbio (Employee, Shareholder), Amelia Tomlinson, PhD, resTORbio (Employee), Sarb Shergill, PhD, resTORbio (Employee), Grace Teo, PhD, resTORbio (Employee), Lloyd Klickstein, MD, PhD, resTORbio (Employee).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB2. TORC1 Inhibition with RTB101 as a Potential Pan-Antiviral Immunotherapy to Decrease the Incidence of Respiratory Tract Infections Due to Multiple Respiratory Viruses in Older Adults
Herramientas de búsqueda: RSS